New diabetes drug takes first step in human testing
NCT ID NCT05491421
Summary
This was an early-stage study to check the safety of a new drug called ZT002, which is being developed for type 2 diabetes. It involved 32 healthy volunteers who received either the drug or a placebo. The main goal was to see if the drug was safe and how it moved through the body, not to treat diabetes at this stage.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Q-Pharm Pty Limited
Herston, Queensland, Australia
Conditions
Explore the condition pages connected to this study.